HUDA BEAUTY RECLAIMS FULL OWNERSHIP AS AN INDEPENDENT BEAUTY BRAND
DUBAI, UAE, June 3, 2025 /PRNewswire/ -- Huda Beauty, the globally renowned beauty brand, proudly announces that it has reclaimed full ownership as an independent brand following the conclusion of its eight-year partnership with TSG Consumer...
Energys Group Secures New Energy Efficient Lighting Contracts Upon Successful Completion of Initial Phase
BILLINGSHURST, UK, June 3, 2025 /PRNewswire/ -- Energys Group Limited (NASDAQ: ENGS) ("Energys Group" or the "Company", together with its subsidiaries, the "Group"), a vertically integrated energy efficiency and decarbonisation solutions provider...
Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)
EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N-glycosylated epitope found on both CEACAM5 and CEACAM6. The expansion cohort for pancreatic ductal adenocarcinoma (PDAC) in the ongoing Phase 1 trial has...
Self Storage Awards Asia Gala Dinner announces winners at Self Storage Expo Asia 2025
HONG KONG, June 3, 2025 /PRNewswire/ -- The Self Storage Association Asia announces the Self Storage Association Awards Asia 2025 winners in Tokyo. The Awards recognise Asia-wide and local excellence in self storage in customer service, the use of...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Monarq Asset Management Announces Strategic Investment From FalconX
NEW YORK, June 3, 2025 /PRNewswire/ -- Monarq Asset Management ("Monarq"), a leading multi-strategy investment firm, formerly known as MNNC Group, today announced a strategic investment from FalconX, a leading institutional digital asset prime...
OHI Group S.A. Announces Consent Solicitation Relating to its U.S.$400,000,000 13.000% Senior Secured Amortizing Notes due 2029 Regulation S Notes: CUSIP L7S61M AB5, ISIN USL7S61MAB59 Rule 144A Notes: CUSIP 67712M AB5, ISIN US67712MAB54 (the "Notes")
Executive Summary — As previously announced, OHI Group S.A. (the "Issuer") is preparing a proposed initial public offering of its shares in the United States, to be registered with the U.S. Securities and Exchange Commission (the "SEC") and likely...
WASHINGTON FREEDOM ANNOUNCES MULTI-YEAR PARTNERSHIP WITH CLOVER
Clover joins Washington Freedom as Official Partner and Kit Sponsor to elevate fan experience and expand cricket's reach in the U.S. WASHINGTON, June 2, 2025 /PRNewswire/ -- Washington Freedom, the first professional cricket franchise representing...
DTX Group Debuts as Global Force, Powered by Strategic Vision and Independence Under Hussein Lookmanjee's Leadership
Backed by years of preparation and a clear global strategy, DTX Group launches to capitalize on emerging market opportunities and reshape the international aviation maintenance landscape. DUBAI, UAE, June 2, 2025 /PRNewswire/ -- DTX Group proudly...